Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


GlaxoSmithKline reported GBP58.6B in Assets for its fiscal quarter ending in March of 2023.

Assets Change
Alcon AG ALC:SW USD 29.29B 82M
Almirall SA ALM:SM EUR 2.15B 7.52M
Amgen AMGN:US USD 88.72B 23.6B
Artemis Alpha ATS:LN GBP 111.08M 18.39M
AstraZeneca AZN:LN USD 96.69B 204M
Bayer BAYN:GR EUR 125.05B 175M
Biogen BIIB:US USD 24.6B 44.3M
Eli Lilly LLY:US USD 53.16B 3.67B
Fresenius FRE:GR EUR 76.55B 138M
Galapagos GLPG:NA EUR 4.63B 102.18M
Genmab GEN:DC DKK 30.39B 116M
Gilead Sciences GILD:US USD 61.88B 1.3B
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Glaxosmithkline GSK:US GBP 58.6B 1.55B
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Lonza Group LONN:SW CHF 17.36B 613M
Merck MRK:GR EUR 48.64B 111M
Novartis NOVN:VX USD 112.24B 5.21B
Orion ORNBV:FH EUR 1.29B 211.3M
Recordati REC:IM EUR 3.98B 16.75M
Regeneron Pharmaceuticals REGN:US USD 30.06B 845.4M
Roche Holding ROG:VX CHF 88.15B 1.42B
Smith & Nephew PLC SN/:LN USD 9.97B 139M
UCB UCB:BB EUR 15.87B 440M